Tag: ADOCIA
Exceptional volumes today: Adocia
During this stock market session on Tuesday December 19, 2023, particularly high trading volumes were detected on the French market. Today, it is the Adocia share which stands out, with…
ADOCIA: Information relating to the number of shares and voting rights as of November 30, 2023 – 12/15/2023 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of November 30, 2023.6 p.m. CET – In accordance with the provisions of article L.233-8 II of the…
Adocia: positive results for the antidiabetic hydrogel AdoShell Islets
(AOF) – Adocia announces that it has revealed additional results on AdoShell Islets, an immunoprotective hydrogel containing Langerhans islets for the treatment of diabetes by cell therapy, during recent international…
Adocia: cash flow of 16.8 million euros as of September 30, visibility until the end of July 2024 – 10/25/2023 at 6:25 p.m.
(AOF) – Adocia announces a cash position of 16.8 million euros as of September 30, 2023 “following operations carried out in the third quarter of 2023”. The biotech specialist in…
Adocia: cash flow of 16.8 million euros as of September 30, visibility until the end of July 2024
(AOF) – Adocia announces a cash position of 16.8 million euros as of September 30, 2023 “following operations carried out in the third quarter of 2023”. The biotech specialist in…
Adocia: positive study data for BC Combo – 10/23/2023 at 1:40 p.m.
(CercleFinance.com) – Adocia announces that its partner Tonghua Dongbao has published positive results on the three clinical studies carried out on the BioChaperone Combo THDB0207 (BC Combo) formulation, containing insulin…
ADOCIA announces oral presentations on AdoShell® Islets during the EASD and IPITA-IXA-CTRMS congresses – 09/25/2023 at 6:00 p.m.
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…
Adocia: cash of 16 million euros as of August 31, 2023
(AOF) – Adocia announces a net loss of 9.39 million euros for the first half of 2023, compared to a positive net result of 4.25 million a year ago. The…
ADOCIA announces the receipt of 500,000 euros for the exercise by IPF Partners of part of its share subscription warrants – 08/31/2023 at 6:00 p.m.
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), the clinical-stage biopharmaceutical company specializing in the development of innovative formulations of proteins and peptides for the treatment of diabetes…
Adocia receives 500,000 euros after the exercise of part of the BSAs of IPF partners – 08/31/2023 at 6:23 p.m.
(AOF) – Adocia announced the exercise by IPF Partners of part of its share subscription warrants (BSA), giving rise to the issue of 204,919 shares at a price of 2.44…
Adocia receives 500,000 euros after the exercise of part of the BSAs of IPF partners
(AOF) – Adocia announced the exercise by IPF Partners of part of its share subscription warrants (BSA), giving rise to the issue of 204,919 shares at a price of 2.44…
ADOCIA: Information relating to the number of shares and voting rights as of July 31, 2023 – 08/30/2023 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of July 31, 20236 p.m. CEST – In accordance with the provisions of Article L.233-8 II of the…